Globus Medical (GMED) PT Lowered to $80 at Stifel on 'Modest Upside Potential'

July 8, 2026 7:21 AM

Stifel analyst Thomas M. Stephan lowered the price target on Globus Medical (NYSE: GMED) to $80.00 (from $95.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found